Wednesday, March 10, 2010
haleybanner.png

From the Desk of Dr. Haley...

HALEY2.jpgAbout 135,400 new cases of colorectal cancer will be diagnosed in the United States this year and 56,700 patients will die.  Early detection can be a Lifesaver. 
The risk of developing colorectal cancer increases with age, as does the occurrence of most cancers. The good news is, colorectal cancer is a slow growing cancer and if detected early is very treatable. Why then are the rates of seniors being tested for this cancer so low? In 2005 only 14 % of Americans over the age of 65 received testing for colon cancer. This is despite the fact that these tests are covered by Medicare. With early detection there is a 90% survival rate.  
What is a screening exam?
 
Medical screening exams are commonly performed on healthy individuals to search for potential problems before they become serious. It is like having your car inspected before your brakes fail. A common example is the Pap Smear which is now a well accepted screening tool. If a Pap smear shows pre-cancerous cells, they can be destroyed and cancer is prevented. This simple procedure has reduced a woman's risk of cervical cancer to 1/50th of the previous levels. The basic premise of screening is that it is much more rewarding to prevent a cancer than find one, even in early curable stages.
 
The same principle holds true for colon cancer. Most people don't realize that colon cancer has become the second leading cause of cancer deaths in this country, second only to lung cancer. In fact, in non-smokers, colon cancer is the number one cancer killer - over 56,000 Americans will die this year alone. That's the bad news. The good news is that colon cancer is also one of the most preventable. This is because the majority of colon cancers begin as a small non-cancerous growth called a polyp. Over time, polyps grow silently and eventually can turn to cancer. This transformation may take as long as ten years during which time you feel perfectly fine, oblivious to what danger awaits you.  

Read more: From the Desk of Dr. Haley...

 

All About Hepatitis

Two For One
It's always nice when one drug can do double duty. That's what new research shows in the June issue of American Journal of Gastroenterology. The old drug Fluvastatin, which has been used for years as a treatment to lower blood cholesterol, can also inhibit Hepatitis C replication.

Unfortunately, Fluvastatin alone won't clear the virus completely, but it may offer another tool in the treatment arsenal for hepatitis C, especially for those not responding well to conventional therapy. As it is now, only about 50% of people respond well to treatment. Read about two people's experience with the current treatment regimen.

One of the nice benefits of using older medicines for newer treatments, besides the obvious cost savings of researching a new drug, is the established safety record. Fluvastatin has been on the market since 1993, and literally millions have taken it safely. It's now in a phase II trial to see if it can provide stronger results by combining it with the standard pegylated interferon and ribavirin. For more about treatment, check out this overview.

Read more: All About Hepatitis

 

How Can You Prevent Colon Cancer?

We continue to learn more about colon cancer and the factors that influence its development. We also have effective screening tools that aid in its early detection. Simple lifestyle changes and widespread routine screening could prevent more than half of all instances of colon cancer.1 In theory, this could prevent 74,000 cases of colon cancer and nearly 28,000 deaths per year in the United States.2

The fact is, colon cancer may be preventable when the early warning signs are detected through routine screening (colonoscopy). If colon cancer does occur, it's treated more successfully when caught early. In fact, more than 90% of people diagnosed when the cancer is confined to the colon or rectum survive more than 5 years.3 Still, less than 50% of Americans aged 50 and older are routinely screened.4

If you know someone who could benefit from learning more about colon cancer screening, send an e-card to encourage them to get screened.


   
[1/1] Colorectal Cancer News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

[1/5] Irritable Bowel Syndrome Patients Not More Likely To Get Colon Cancer

[2/5] News From The Annals Of Family Medicine: March/April 2010

[3/5] Colorectal Cancer In China

[4/5] Obesity Associated With Risk Of Colorectal Tumors Without Microsatellite Instability

[5/5] Physicians Come Together On National Colorectal Cancer Awareness And Screening Day
[1/1] Acid Reflux / GERD News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

[1/5] Anti-Hypertensive Drugs To Enhance Esophageal Contraction

[2/5] New Endoscopic Treatment May Spare Barrett's Esophagus Patients From Surgery

[3/5] Shape Of Barrett's Epithelium Effects Prevalence Of Erosive Esophagitis

[4/5] New Hope For Therapy In Heartburn-Related Cancer

[5/5] Development Of ADX10059 Ended For Long-Term Use
[1/1] GastroIntestinal / Gastroenterology News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

[1/5] Perceived Health Can Predict Survival Of Esophago-gastric Cancer

[2/5] Irritable Bowel Syndrome Patients Not More Likely To Get Colon Cancer

[3/5] Discovery Of Gene For Newly Recognized Disease In Amish Children

[4/5] The Long-Term Consequences Of Intravenous Nutrition On Children's Health

[5/5] ESMO Conference On Sarcoma And GIST: Spotlight On Rare Tumors In Hunt For New Cancer Treatments
[1/1] Liver Disease / Hepatitis News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

[1/5] Hepatitis C And Insulin Resistance - Surprising Findings

[2/5] Link Between Hepatitis C And Insulin Resistance Surprises Scientists

[3/5] Novel Criteria To Differentiate Fibrosis From Steatohepatitis

[4/5] Groundbreaking Research To Find Vaccine For Hepatitis C

[5/5] Post-Op Liver Cancer Complications More Frequent At Low-Volume Hospitals
Restore Default Settings